Human β‐defensin‐2 functions as a chemotactic agent for tumour necrosis factor‐α‐treated human neutrophils
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Summary: Neutrophils are the effector cells in both innate and adaptive immunity, where they perform the functions of phagocytosis and killing of bacteria. They respond to a large number of chemoattractants, but their response to epithelial cell‐derived human β‐defensins (hBD) has not been investigated. Here we report that hBD‐2, but not hBD‐1, is a specific chemoattractant for tumour necrosis factor (TNF)‐α‐treated human neutrophils. The optimal concentration required for maximal chemotactic activity was 5 µg/ml. The effect of hBD‐2 on neutrophils was dependent on the G‐protein‐phospholipase C pathway, as demonstrated by inhibition by pertussis toxin and U‐73122. In addition, ligand‐receptor analysis indicated that the binding of hBD‐2 was markedly inhibited by macrophage inflammatory protein (MIP)‐3α, a specific and unique ligand for CCR6. Furthermore, anti‐CCR6 antibody could almost completely suppress the cell migration induced by hBD‐2, suggesting that hBD‐2 mainly utilizes CCR6 as a functional receptor. Thus, our finding that hBD‐2 is a potent chemoattractant for human neutrophils through specific receptors provides a novel mechanism by which this peptide contributes to the host defence system by recruiting neutrophils to inflammation/infection sites. This also suggests an important link between epithelial cell‐derived antibacterial peptides and neutrophils during infection or inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LIGAND: A versatile computerized approach for characterization of ligand-binding systems
Munson, P. J., & Rodbard, D. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90515-1 · Cited by 8,429
Atopic Dermatitis: Global Epidemiology and Risk Factors
Nutten, S. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000370220 · Cited by 3,055
Rollins, B. J. (1997) · Blood · doi:10.1182/blood.v90.3.909 · Cited by 1,984
Endogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R. L., & Leung, D. Y. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021481 · Cited by 1,960
β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6
Yang, D., Chertov, O., Bykovskaia, S. N., Chen, Q., Buffo, M. J., Shogan, J., Anderson, M., Schröder, J. M., Wang, J. M., Howard, O. M. Z., et al. (1999) · Science · doi:10.1126/science.286.5439.525 · Cited by 1,809
Peptide Antibiotics and Their Role in Innate Immunity
Boman, H. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.61 · Cited by 1,665
Dieu, M.-C., Vanbervliet, B., Vicari, A., Bridon, J.-M., Oldham, E., Aït-Yahia, S., Brière, F., Zlotnik, A., Lebecque, S., & Caux, C. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.373 · Cited by 1,425
A peptide antibiotic from human skin
Harder, J., Bartels, J., Christophers, E., & Schröder, J.-M. (1997) · Nature · doi:10.1038/43088 · Cited by 1,363
Isolation and Characterization of Human μ-Defensin-3, a Novel Human Inducible Peptide Antibiotic
Harder, J., Bartels, J., Christophers, E., & Schröder, J.-M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008557200 · Cited by 1,311
Yang, D., Chen, Q., Schmidt, A. P., Anderson, G. M., Wang, J. M., Wooters, J., Oppenheim, J. J., & Chertov, O. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1069 · Cited by 1,240
Human β-Defensin-1 Is a Salt-Sensitive Antibiotic in Lung That Is Inactivated in Cystic Fibrosis
Goldman, M. J., Anderson, G. M., Stolzenberg, E. D., Kari, U. P., Zasloff, M., & Wilson, J. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81895-4 · Cited by 1,080
Roles of PLC-β2 and -β3 and PI3Kγ in Chemoattractant-Mediated Signal Transduction
Li, Z., Jiang, H., Xie, W., Zhang, Z., Smrcka, A. V., & Wu, D. (2000) · Science · doi:10.1126/science.287.5455.1046 · Cited by 807
Human beta-defensin-1: an antimicrobial peptide of urogenital tissues.
Valore, E. V., Park, C. H., Quayle, A. J., Wiles, K. R., McCray, P. B., & Ganz, T. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1861 · Cited by 724
Antimicrobial peptides in mammalian and insect host defence
Lehrer, R. I., & Ganz, T. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)80005-3 · Cited by 723
Rollins, B. J. (1997) · PubMed · Cited by 603
Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung.
Bals, R., Wang, X., Wu, Z., Freeman, T., Bafna, V, Zasloff, M., & Wilson, J. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2410 · Cited by 577
García, J.-R. C., Krause, A., Schulz, S., Rodríguez-Jiménez, F.-J., Klüver, E., Adermann, K., Forssmann, U., Frimpong-Boateng, A., Bals, R., & Forssmann, W.-G. (2001) · The FASEB Journal · doi:10.1096/fj.00-0865fje · Cited by 470
García, J.-R., Jaumann, F., Schulz, S., Krause, A., Rodríguez-Jiménez, J., Forssmann, U., Adermann, K., Klüver, E., Vogelmeier, C., Becker, D., et al. (2001) · Cell and Tissue Research · doi:10.1007/s004410100433 · Cited by 410
Lehrer, R. I., Ganz, T., Selsted, M. E., Babior, B. M., & Curnutte, J. T. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-2-127 · Cited by 372
Defensins: Endogenous antibiotic peptides of animal cells
Lehrer, R. I., Ganz, T., & Selsted, M. E. (1991) · Cell · doi:10.1016/0092-8674(91)90632-9 · Cited by 348
Niyonsaba, F., Someya, A., Hirata, M., Ogawa, H., & Nagaoka, I. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200104)31:4<1066::aid-immu1066>3.0.co;2-# · Cited by 347
Self-citationSynergistic and additive killing by antimicrobial factors found in human airway surface liquid
Singh, P. K., Tack, B. F., McCray, P. B., & Welsh, M. J. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.5.l799 · Cited by 341
Liu, A. Y., Destoumieux, D., Wong, A. V., Park, C. H., Valore, E. V., Liu, L., & Ganz, T. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01651.x · Cited by 323
Paneth cell defensins: Endogenous peptide components of intestinal host defense
Ouellette, A. J., & Selsted, M. E. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.11.8836041 · Cited by 287
Marks, P. W. (1990) · The Journal of Cell Biology · doi:10.1083/jcb.110.1.43 · Cited by 259
Epithelial Antimicrobial Peptides: Review and Significance for Oral Applications
Weinberg, A., Krisanaprakornkit, S., & Dale, B. A. (1998) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411980090040201 · Cited by 253
Niyonsaba, F., Iwabuchi, K., Matsuda, H., Ogawa, H., & Nagaoka, I. (2002) · International Immunology · doi:10.1093/intimm/14.4.421 · Cited by 241
Self-citationIdentification of Multiple Novel Epididymis-Specific β-Defensin Isoforms in Humans and Mice
Yamaguchi, Y., Nagase, T., Makita, R., Fukuhara, S., Tomita, T., Tominaga, T., Kurihara, H., & Ouchi, Y. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2516 · Cited by 228
(1999) · PubMed · Cited by 207
Johnston, B., Burns, A. R., Suematsu, M., Issekutz, T. B., Woodman, R. C., & Kubes, P. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5208 · Cited by 207
Bonecchi, R., Polentarutti, N., Luini, W., Borsatti, A., Bernasconi, S., Locati, M., Power, C., Proudfoot, A., Wells, T. N. C., Mackay, C., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.1.474 · Cited by 187
Tsutsumi-Ishii, Y., & Nagaoka, I. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.4226 · Cited by 175
Self-citationCytokine-Activated Endothelial Cells Delay Neutrophil Apoptosis in Vitro and in Vivo
Coxon, A., Tang, T., & Mayadas, T. N. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.7.923 · Cited by 174
Yamashiro, S., Kamohara, H., Wang, J.-M., Yang, D., Gong, W.-H., & Yoshimura, T. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.5.698 · Cited by 167
Expression of natural peptide antibiotics in human skin
Fulton, C., Anderson, G. M., Zasloff, M., Bull, R., & Quinn, A. G. (1997) · The Lancet · doi:10.1016/s0140-6736(05)63574-x · Cited by 163
Epithelial peptide antibiotics
Schröder, J.-M. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00226-3 · Cited by 163
Atkinson, Y. H., Marasco, W. A., Lopez, A. F., & Vadas, M. A. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113381 · Cited by 161
Figari, I., Mori, N., & Palladino, M. J. (1987) · Blood · doi:10.1182/blood.v70.4.979.979 · Cited by 150
Expression of CCR6 and CD83 by cytokine-activated human neutrophils
Yamashiro, S., Wang, J., Yang, D., Gong, W., Kamohara, H., & Yoshimura, T. (2000) · Blood · doi:10.1182/blood.v96.12.3958 · Cited by 138
Chemoattractant properties of PR-39, a neutrophil antibacterial peptide
Huang, H.-J., Ross, C. R., & Blecha, F. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.61.5.624 · Cited by 135
Peptidergic pathway in human skin and rat peritoneal mast cell activation
Mousli, M., Hugli, T. E., Landry, Y., & Bronner, C. (1994) · Immunopharmacology · doi:10.1016/0162-3109(94)90002-7 · Cited by 131
Berger, M., Wetzler, E., & Wallis, R. S. (1988) · Blood · doi:10.1182/blood.v71.1.151.151 · Cited by 128
Bajaj, M. S., Kew, R. R., Webster, R. O., & Hyers, T. M. (1992) · Inflammation · doi:10.1007/bf00918813 · Cited by 90
Tennenberg, S. D., & Solomkin, J. S. (1990) · Journal of Leukocyte Biology · doi:10.1002/jlb.47.3.217 · Cited by 61
Meshulam, T., Proto, P. J., Diamond, R. D., & Melnick, D. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.6.1954 · Cited by 56
Elsner, J., Dichmann, S., Dobos, G., & Kapp, A. (1996) · Journal of Cellular Physiology · Cited by 43
Perez, H. D., Elfman, F., Marder, S. R., Lobo, E., & Ives, H. E. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114105 · Cited by 41
Evaluation of the expression of human CAP18 gene during neutrophil maturation in the bone marrow
Nagaoka, I., Hirata, M., Sugimoto, K., Tsutsumi‐Ishii, Y., Someya, A., Saionji, K., & Igari, J. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.64.6.845 · Cited by 41
Self-citationModulation of neutrophil phospholipase C activity and cyclic AMP levels by fMLP-OMe analogues
Ferretti, M. E., Nalli, M., Biondi, C., Colamussi, M. L., Pavan, B., Traniello, S., & Spisani, S. (2001) · Cellular Signalling · doi:10.1016/s0898-6568(01)00140-1 · Cited by 29
Evaluation of the effects of defensins on neutrophil functions
Yomogida, S., Nagaoka, I., Saito, K., & Yamashita, T. (1996) · Inflammation Research · doi:10.1007/bf02265117 · Cited by 22
Self-citation
Cited by
Alarmins: chemotactic activators of immune responses
Oppenheim, J. J., & Yang, D. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.06.002 · Cited by 786
The Roles of Antimicrobial Peptides in Innate Host Defense
Diamond, G., Beckloff, N., Weinberg, A., & Kisich, K. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788682325 · Cited by 642
Psoriasis is associated with increased β-defensin genomic copy number
Hollox, E. J., Huffmeier, U., Zeeuwen, P. L. J. M., Palla, R., Lascorz, J., Rodijk-Olthuis, D., van de Kerkhof, P. C. M., Traupe, H., de Jongh, G., Heijer, M. D., et al. (2008) · Nature Genetics · doi:10.1038/ng.2007.48 · Cited by 627
Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity
Kamen, D. L., & Tangpricha, V. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0590-9 · Cited by 560
Niyonsaba, F., Ushio, H., Nakano, N., Ng, W., Sayama, K., Hashimoto, K., Nagaoka, I., Okumura, K., & Ogawa, H. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700599 · Cited by 544
Self-citation
Metadata
- Authors
- Niyonsaba, F., Ogawa, H., & Nagaoka, I.
- Venue
- Immunology
- Publisher
- Wiley
- Published
- 2004-02-25
- Volume
- 111
- Issue
- 3
- Pages
- 273-281
- ISSN
- 0019-2805 (ISSN-L)
- 1365-2567
- OpenAlex
- W2079884351
- Cited by
- 265
- References
- 50
- FWCI
- 17.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.